We analyzed the main approaches to the modeling of Alzheimer’s disease for studying the effectiveness of cell therapy. Recent advances in regenerative medicine in the field of neuroscience create prospects for the use of various cell preparations for the treatment of Alzheimer’s disease. Experimental data on the use of neural stem/progenitor cells, mesenchymal stem cells, embryonic stem cells, and induced pluripotent stem cells in various models of Alzheimer’s disease are presented. Of particular importance is the standardization of protocols. The use of a standardized protocol in modeling of Alzheimer’s disease will allow a comparative analysis of the effectiveness and safety of treatment to identify the optimal cell preparation. The data obtained on experimental animals can form the basis for further preclinical and clinical studies of cell therapy for Alzheimer’s disease.
Similar content being viewed by others
References
Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer’s disease. World J. Stem Cells. 2020;12(8):787-802. doi: https://doi.org/10.4252/wjsc.v12.i8.787
Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur. J. Neurol. 2018;25(1):59-70. doi: https://doi.org/10.1111/ene.13439
Si Z, Wang X. Stem cell therapies in Alzheimer’s disease: applications for disease modeling. J. Pharmacol. Exp. Ther. 2021;377(2):207-217. doi: https://doi.org/10.1124/jpet.120.000324
Appleby BS, Cummings JL. Discovering new treatments for Alzheimer’s disease by repurposing approved medications. Curr. Top. Med. Chem. 2013;13(18):2306-2327. doi: https://doi.org/10.2174/15680266113136660162
Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clin. Interv. Aging. 2008;3(2):211-225.
Qin C, Wang K, Zhang L, Bai L. Stem cell therapy for Alzheimer’s disease: An overview of experimental models and reality. Animal Model Exp. Med. 2022;5(1):15-26. doi: https://doi.org/10.1002/ame2.12207
Bryan KJ, Lee HG, Perry G, Smith MA, Casadesus G. Transgenic mouse models of Alzheimer’s disease: behavioral testing and considerations. Methods of Behavior Analysis in Neuroscience. Buccafusco JJ, ed. Boca Raton, 2009. P. 2-14.
Pentkowski NS, Rogge-Obando KK, Donaldson TN, Bouquin SJ, Clark BJ. Anxiety and Alzheimer’s disease: behavioral analysis and neural basis in rodent models of Alzheimer’s-related neuropathology. Neurosci. Biobehav. Rev. 2021;127:647-658. doi: https://doi.org/10.1016/j.neubiorev.2021.05.005
Puzzo D, Lee L, Palmeri A, Calabrese G, Arancio O. Behavioral assays with mouse models of Alzheimer’s disease: practical considerations and guidelines. Biochem. Pharmacol. 2014;88(4):450-467. doi: https://doi.org/10.1016/j.bcp.2014.01.011
Tian H, Ding N, Guo M, Wang S, Wang Z, Liu H, Yang J, Li Y, Ren J, Jiang J, Li Z. Analysis of learning and memory ability in an Alzheimer’s disease mouse model using the Morris water maze. J. Vis. Exp. 2019;(152). doi: https://doi.org/10.3791/60055
Sacrey LA, Alaverdashvili M, Whishaw IQ. Similar hand shaping in reaching-for-food (skilled reaching) in rats and humans provides evidence of homology in release, collection, and manipulation movements. Behav. Brain Res. 2009;204(1):153-161. doi: https://doi.org/10.1016/j.bbr.2009.05.035
Lawlor PA, Bland RJ, Das P, Price RW, Holloway V, Smithson L, Dicker BL, During MJ, Young D, Golde TE. Novel rat Alzheimer’s disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels. Mol. Neurodegener. 2007;2:11. doi: https://doi.org/10.1186/1750-1326-2-11
Song Z, Zheng M, Ding J, Xu Y, Ji MJ, Liu C. Detecting amyloid-β accumulation via immunofluorescent staining in a mouse model of Alzheimer’s disease. J. Vis. Exp. 2021. N 170. doi: https://doi.org/10.3791/62254
Galeano P, Martino Adami PV, Do Carmo S, Blanco E, Rotondaro C, Capani F, Castaño EM, Cuello AC, Morelli L. Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer’s disease. Front. Behav. Neurosci. 2014;8:321. doi: https://doi.org/10.3389/fnbeh.2014.00321
Serneels L, T’Syen D, Perez-Benito L, Theys T, Holt MG, De Strooper B. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease. Mol. Neurodegener. 2020;15(1):60. doi: https://doi.org/10.1186/s13024-020-00399-z
Filip T, Mairinger S, Neddens J, Sauberer M, Flunkert S, Stanek J, Wanek T, Okamura N, Langer O, Hutter-Paier B, Kuntner C. Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling. Alzheimers Res. Ther. 2021;13(1):175. doi: https://doi.org/10.1186/s13195-021-00916-2
Baerends E, Soud K, Folke J, Pedersen AK, Henmar S, Konrad L, Lycas MD, Mori Y, Pakkenberg B, Woldbye DPD, Dmytriyeva O, Pankratova S. Modeling the early stages of Alzheimer’s disease by administering intracerebroventricular injections of human native Aβ oligomers to rats. Acta Neuropathol. Commun. 2022;10(1):113. doi: https://doi.org/10.1186/s40478-022-01417-5
Dmytriyeva O, Belmeguenai A, Bezin L, Soud K, Drucker Woldbye DP, Gøtzsche CR, Pankratova S. Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology. Neurobiol. Aging. 2019;81:88-101. doi: https://doi.org/10.1016/j.neurobiolaging.2019.05.003
Singh A, Kumar A. Comparative analysis of intrahippocampal amyloid beta (1-42) and it is intracerebroventricular streptozotocin models of Alzheimer’s disease: possible behavioral, biochemical, mitochondrial, cellular and histopathological evidences. J. Alzheimers Dis. Parkinsonism. 2016;6(1). doi: https://doi.org/10.4172/2161-0460.1000208
O’Hare E, Scopes DI, Treherne JM, Monaghan J, Palmer PM, Amijee H, Kim EM. Novel anti-inflammatory compound SEN1176 alleviates behavioral deficits induced following bilateral intrahippocampal injection of aggregated amyloid-β1-42. J. Alzheimers Dis. 2011;25(2):219-229. doi: https://doi.org/10.3233/JAD-2011-100044
Zhu D, Yang N, Liu YY, Zheng J, Ji C, Zuo PP. M2 macrophage transplantation ameliorates cognitive dysfunction in amyloid-β-treated rats through regulation of microglial polarization. J. Alzheimers Dis. 2016;52(2):483-495. doi: https://doi.org/10.3233/JAD-151090
Takeda S, Sato N, Niisato K, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Kano M, Morishita R. Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Res. 2009;1280:137-147. doi: https://doi.org/10.1016/j.brainres.2009.05.035
Paulo SL, Rodrigues RS, Shvachiy L, Ribeiro FF, Solá S, Sebastião AM, Xapelli S. Neurogenesis in a rat model of sporadic Alzheimer’s disease: PS227. Porto Biomed. J. 2017;2(5):205. doi: https://doi.org/10.1016/j.pbj.2017.07.072
Facchinetti R, Bronzuoli MR, Scuderi C. An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid β-peptide (1-42). Methods Mol. Biol. 2018;1727:343-352. doi: https://doi.org/10.1007/978-1-4939-7571-6_25
Ravelli KG, Rosário BD, Camarini R, Hernandes MS, Britto LR. Intracerebroventricular streptozotocin as a model of Alzheimer’s disease: neurochemical and behavioral characterization in mice. Neurotox. Res. 2017;31(3):327-333. doi: https://doi.org/10.1007/s12640-016-9684-7
Gáspár A, Hutka B, Ernyey AJ, Tajti BT, Varga BT, Zádori ZS, Gyertyán I. Performance of the intracerebroventricularly injected streptozotocin Alzheimer’s disease model in a translationally relevant, aged and experienced rat population. Sci. Rep. 2022;12(1):20247. doi: https://doi.org/10.1038/s41598-022-24292-5
Petrasek T, Skurlova M, Maleninska K, Vojtechova I, Kristofikova Z, Matuskova H, Sirova J, Vales K, Ripova D, Stuchlik A. A rat model of Alzheimer’s disease based on Abeta42 and pro-oxidative substances exhibits cognitive deficit and alterations in glutamatergic and cholinergic neurotransmitter systems. Front. Aging Neurosci. 2016;8:83. doi: https://doi.org/10.3389/fnagi.2016.00083
Andrew MK, Tierney MC. The puzzle of sex, gender and Alzheimer’s disease: Why are women more often affected than men? Women’s Health (Lond). 2018;14(2):1745506518817995. doi: https://doi.org/10.1177/1745506518817995
Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer’s disease. Stem Cell Rev. Rep. 2022;18(2):781-791. doi: https://doi.org/10.1007/s12015-021-10321-9
McGinley LM, Kashlan ON, Bruno ES, Chen KS, Hayes JM, Kashlan SR, Raykin J, Johe K, Murphy GG, Feldman EL. Human neural stem cell transplantation improves cognition in a murine model of Alzheimer’s disease. Sci. Rep. 2018;8(1):14776. doi: https://doi.org/10.1038/s41598-018-33017-6
Petrasek T, Vojtechova I, Lobellova V, Popelikova A, Janikova M, Brozka H, Houdek P, Sladek M, Sumova A, Kristofikova Z, Vales K, Stuchlík A. The McGill transgenic rat model of Alzheimer’s disease displays cognitive and motor impairments, changes in anxiety and social behavior, and altered circadian activity. Front. Aging Neurosci. 2018;10:250. doi: https://doi.org/10.3389/fnagi.2018.00250
Zhu Q, Zhang N, Hu N, Jiang R, Lu H, Xuan A, Long D, Chen Y. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer’s disease. Mol. Med. Rep. 2020;21(3):41172-1180. doi: https://doi.org/10.3892/mmr.2020.10918
Zhang HA, Yuan CX, Liu KF, Yang QF, Zhao J, Li H, Yang QH, Song D, Quan ZZ, Qing H. Neural stem cell transplantation alleviates functional cognitive deficits in a mouse model of tauopathy. Neural Regen. Res. 2022;17(1):152-162. doi: https://doi.org/10.4103/1673-5374.314324
Kloskowska E, Pham TM, Nilsson T, Zhu S, Oberg J, Codita A, Pedersen LA, Pedersen JT, Malkiewicz K, Winblad B, Folkesson R, Benedikz E. Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer’s disease. J. Cell. Mol. Med. 2010;14(6B):1816-1823. doi: https://doi.org/10.1111/j.1582-4934.2009.00809.x
Doshmanziari M, Shirian S, Kouchakian MR, Moniri SF, Jangnoo S, Mohammadi N, Zafari F. Mesenchymal stem cells act as stimulators of neurogenesis and synaptic function in a rat model of Alzheimer’s disease. Heliyon. 2021;7(9):e07996. doi: https://doi.org/10.1016/j.heliyon.2021.e07996
Kazemiha M, Sarveazad A, Moradi F, Ramezanpour F, Vosoogh M, Doshmanziari M, Shariatpanahi M, Eftekharzadeh M. Histological and behavioral alterations following hADSCs intravenous administration in Alzheimer’s rat model. Thrita 2019;8(1):e99975. doi: https://doi.org/10.5812/thrita.99975
Finder VH. Alzheimer’s disease: a general introduction and pathomechanism. J. Alzheimers Dis. 2010;22(Suppl. 3):5-19. doi: https://doi.org/10.3233/JAD-2010-100975
Fujiwara N, Shimizu J, Takai K, Arimitsu N, Saito A, Kono T, Umehara T, Ueda Y, Wakisaka S, Suzuki T, Suzuki N. Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells. Neurosci. Lett. 2013;557(Pt B):129-134.
Delarue Q, Guerout N. Transplantation of olfactory ensheathing cells: properties and therapeutic effects after transplantation into the lesioned nervous system. Neuroglia. 2022;3(2):1-22. doi: https://doi.org/10.3390/neuroglia3010001
Stepanova OV, Voronova AD, Chadin AV, Valikhov MP, Semkina AS, Karsuntseva EK, Chekhonin IV, Shishkina VS, Reshetov IV, Chekhonin VP. Efficiency of human olfactory ensheathing cell transplantation into spinal cysts to improve mobility of the hind limbs. Stem Cells Dev. 2019;28(18):1253-1263. doi: https://doi.org/10.1089/scd.2019.0092
Tabakow P, Jarmundowicz W, Czapiga B, Fortuna W, Miedzybrodzki R, Czyz M, Huber J, Szarek D, Okurowski S, Szewczyk P, Gorski A, Raisman G. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 2013;22(9):1591-1612. doi: https://doi.org/10.3727/096368912X663532
Voronova AD, Stepanova OV, Valikhov MP, Chadin AV, Dvornikov AS, Reshetov IV, Chekhonin VP. Preparation of human olfactory ensheathing cells for the therapy of spinal cord injuries. Bull. Exp. Biol. Med. 2018;164(4):523-527. doi: https://doi.org/10.1007/s10517-018-4025-x
Yao R, Murtaza M, Velasquez JT, Todorovic M, Rayfield A, Ekberg J, Barton M, St John J. Olfactory ensheathing cells for spinal cord injury: sniffing out the issues. Cell Transplant. 2018;27(6):879-889. doi: https://doi.org/10.1177/0963689718779353
Mackay-Sim A, Féron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, Fronek P, Gray C, Kerr G, Licina P, Nowitzke A, Perry C, Silburn PA, Urquhart S, Geraghty T. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain. 2008;131(Pt 9):2376-2386. doi: https://doi.org/10.1093/brain/awn173
Stepanova OV, Voronova AD, Sosnovtseva AO, Stepanenko AA, Chadin AV, Karsuntseva EK, Fursa GA, Valikhov MP, Semkina AS, Vorobyev PO, Reshetov IV, Chekhonin VP. Study of the therapeutic efficiency of transduced olfactory ensheathing cells in spinal cord cysts. Stem Cells Dev. 2022;31(1-2):9-17. doi: https://doi.org/10.1089/scd.2021.0265
Stepanova OV, Voronova AD, Chadin AV, Valikhov MP, Abakumov MA, Reshetov IV, Chekhonin VP. Isolation of rat olfactory ensheathing cells and their use in the therapy of posttraumatic cysts of the spinal cord. Bull. Exp. Biol. Med. 2018;165(1):132-135. doi: https://doi.org/10.1007/s10517-018-4114-x
Stepanova OV, Voronova AD, Fursa GA, Karsuntseva EK, Valikhov MP, Chadin AV, Vishnevskii DA, Reshetov IV, Chekhonin VP. Preparation of adhesion culture of neural stem/progenitor cells of the olfactory mucosa for the treatment of spinal cord injuries. Bull. Exp. Biol. Med. 2020;170(1):3158-163. doi: https://doi.org/10.1007/s10517-020-05023-0
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 2, pp. 71-76, June, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Voronova, A.D., Karsuntseva, E.K., Stepanova, O.V. et al. Modeling of Alzheimer’s Disease to Study the Efficacy of Cell Therapy (Review). Bull Exp Biol Med 175, 524–529 (2023). https://doi.org/10.1007/s10517-023-05899-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05899-8